CARB-X Awards DZD $6.2M to Develop New Test To Diagnose Deadly Superbug Infections
May 11 2020
Funding award is the first whole genome sequencing and machine learning technology in CARB-X portfolio
Read More
New Genomic Tests Aim to Diagnose Deadly Infections Faster
February 24 2020
DZD included in the new class of diagnostics for infectious diseases
Read More
Diagnostic Startups Take on Growing Threat of Antibiotic-Resistant Bugs
January 14 2020
DZD featured in WSJ review of emerging diagnostic companies
Read More
Genomics Links Fecal Transplant Recipient Infections to Drug-Resistant E. coli Donor
October 31 2019
EpiXact uses sequencing to confirm cause of patient death in a clinical trial with wide ranging implications
Read More
HBS Impact – Advancing Diagnostics That Can Save Lives
September 1 2019
DZD featured in Harvard Business School alumni publication on Life Lab ventures
Read More
AI Algorithm to Fight HAI Gets Support with NIH Award
July 10 2019
DZD funding award for hospital-acquired infection technology reviewed by HCIT
Read More